{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:39:16Z","timestamp":1777426756032,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.braindev.2010.12.007","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T09:16:08Z","timestamp":1294910168000},"page":"627-631","source":"Crossref","is-referenced-by-count":14,"title":["Rett syndrome: The state of clinical and basic research, and future perspectives"],"prefix":"10.1016","volume":"33","author":[{"given":"Toyojiro","family":"Matsuishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Nagamitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2010.12.007_b0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410230432","article-title":"Diagnostic criteria for Rett syndrome","volume":"23","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0387-7604(01)00193-0","article-title":"Guidelines for reporting clinical features in cases with MECP2 mutations","volume":"23","author":"Kerr","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0285","unstructured":"Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update clinically appreciable diagnostic criteria in Rett syndrome. Comments to Rett syndrome clinical criteria consensus panel satellite to European Pediatric Neurology Society Meeting, 11 September 2001, Germany: Baden Baden, Eur J Pediatr Neurol 2002; 6: 1\u20135."},{"key":"10.1016\/j.braindev.2010.12.007_b0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.braindev.2010.12.007_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.braindev.2010.12.007_b0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg1878","article-title":"Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized","volume":"7","author":"Bienvenu","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.braindev.2010.12.007_b0035","first-page":"S88","article-title":"Rett syndrome and MECP2-status of knowledge 10years after the genes. Invited speaker of Segawa program","volume":"42","author":"Franke","year":"2010","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.braindev.2010.12.007_b0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0387-7604(87)80074-8","article-title":"Pathophysiology of Rett syndrome","volume":"9","author":"Nomura","year":"1987","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0045","first-page":"S46","article-title":"Polysomnography in the Rett syndrome","volume":"14","author":"Segawa","year":"1992","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.410250109","article-title":"Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome","volume":"25","author":"Zoghbi","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0022-3476(88)80060-X","article-title":"Cerebrospinal fluid values for monoamine metabolites, gamma aminobutyric acid, and other amino compounds in Rett syndrome","volume":"112","author":"Perry","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2010.12.007_b0060","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.braindev.2010.12.007_b0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0887-8994(89)90049-0","article-title":"Rett syndrome: biogenic amines and metabolites in postmortem brain","volume":"5","author":"Lekman","year":"1989","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2005.05.056","article-title":"Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse","volume":"386","author":"Ide","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2010.12.007_b0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2007-979741","article-title":"Alteration in dopaminergic function in Rett syndrome","volume":"26","author":"Wenk","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2010.12.007_b0080","first-page":"416","article-title":"Pathological changes in substantia nigra and basal forebrain neurons in Rett syndrome","volume":"28","author":"Kitt","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/1531-8249(200006)47:6<801::AID-ANA13>3.0.CO;2-L","article-title":"Decreased cerebrospinal fluid levels of \u03b2-phenylethylamine in patients with Rett syndrome","volume":"47","author":"Satoi","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jnnp.63.6.754","article-title":"Decreased cerebrospinal fluid \u03b2-phenylethylamine in Parkinson\u2019s disease","volume":"63","author":"Zhou","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2010.12.007_b0095","first-page":"340","article-title":"Hyperendorphinism in Rett syndrome: cause or result?","volume":"24","author":"Myer","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0387-7604(12)80183-5","article-title":"Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta endorphins","volume":"12","author":"Budden","year":"1990","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ana.410420621","article-title":"Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome","volume":"42","author":"Matsuishi","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0306-4522(86)90041-2","article-title":"Substance P in the human brain","volume":"17","author":"Mai","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.braindev.2010.12.007_b0115","first-page":"196","article-title":"Interaction of substance P with respiratory control system in the rat","volume":"228","author":"Hender","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.braindev.2010.12.007_b0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0887-8994(00)00120-X","article-title":"Substance P immunoreactivity in Rett syndrome","volume":"22","author":"Deguchi","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3940(93)90877-N","article-title":"Neurotrophic effects of substance P on hippocampal neurons in vitro","volume":"164","author":"Whitty","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2010.12.007_b0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1469-8749.1998.tb15445.x","article-title":"Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment","volume":"40","author":"McArthur","year":"1998","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0387-7604(98)00072-2","article-title":"Serum melatonin kinetics and long-term melatonin treatment for sleep disturbance in Rett syndrome","volume":"21","author":"Miyamoto","year":"1999","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0140","first-page":"570","article-title":"Sleep disorder in Rett syndrome and melatonin treatment","volume":"21","author":"Yamashita","year":"1999","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/088307389601100407","article-title":"Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome","volume":"11","author":"Lappalainen","year":"1996","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.braindev.2010.12.007_b0155","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation","volume":"302","author":"Martinowich","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.braindev.2010.12.007_b0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.braindev.2010.12.007_b0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbd.2008.12.011","article-title":"Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations","volume":"34","author":"Larimore","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.braindev.2010.12.007_b0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","article-title":"Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains","volume":"66","author":"Itoh","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0175","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.braindev.2010.12.007_b0180","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1531-8249(199904)45:4<541::AID-ANA21>3.0.CO;2-2","article-title":"Development of amino acid receptors in frontal cortex from girls with Rett syndrome","volume":"45","author":"Blue","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0185","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2008-1071344","article-title":"Elevated CSF glutamate in Rett syndrome","volume":"23","author":"Hamberger","year":"1992","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2010.12.007_b0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-510X(97)00223-2","article-title":"Decrease in benzodiazepine receptor binding in the brain of adult Rett syndrome","volume":"154","author":"Yamashita","year":"1998","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.braindev.2010.12.007_b0195","first-page":"5225","article-title":"Ketogenic diet in Rett syndrome","volume":"24","author":"Haas","year":"1986","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.braindev.2010.12.007_b0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0887-8994(90)90028-Y","article-title":"Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities","volume":"6","author":"Wakai","year":"1990","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0387-7604(12)80283-X","article-title":"The Rett syndrome and CSF lactic patterns","volume":"14","author":"Matsuishi","year":"1992","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/088307389400900105","article-title":"Kato H Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome","volume":"9","author":"Matsuishi","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0280","doi-asserted-by":"crossref","unstructured":"Murakami Y, Yamashita Y, Matsuish T, Iwanaga R, Kato H. Cerebral oxygenation and hemodynamics during hyperventilation and sleep in patients with Rett syndrome. Brain Dev; 20: 574\u2013578.","DOI":"10.1016\/S0387-7604(98)00053-9"},{"key":"10.1016\/j.braindev.2010.12.007_b0220","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S0387-7604(01)00332-1","article-title":"Rett syndrome neuropathology review 2000","volume":"23","author":"Armstrong","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0225","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S0387-7604(01)00358-8","article-title":"Reduced expression of neuropeptides can be related to respiratory disturbances in Rett syndrome","volume":"23","author":"Saito","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0230","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1531-8249(200005)47:5<670::AID-ANA20>3.0.CO;2-F","article-title":"Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes","volume":"47","author":"Amir","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.12.007_b0235","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0387-7604(01)00333-3","article-title":"The biological function of the methyl-CpG binding protein MECP2 and its implication in Rett syndrome","volume":"23","author":"Nan","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0240","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jmg.37.8.608","article-title":"Mutation analysis of the Methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome","volume":"37","author":"Obata","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.braindev.2010.12.007_b0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.braindev.2004.06.003","article-title":"Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms","volume":"27","author":"Fukuda","year":"2005","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0250","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/S0387-7604(01)00378-3","article-title":"Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech","volume":"23","author":"Yamashita","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0255","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0387-7604(01)00380-1","article-title":"Neurobiology and neurochemistry of Rett syndrome","volume":"23","author":"Matsuishi","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.12.007_b0260","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00075197-200207000-00007","article-title":"Ghrelin: a novel peptide for growth hormone release and feeding regulation","volume":"5","author":"Yoshihara","year":"2002","journal-title":"Curr Opin Nutr Metab Care"},{"key":"10.1016\/j.braindev.2010.12.007_b0265","doi-asserted-by":"crossref","unstructured":"Okabe Y, Kusaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E, et al. Neural development of methyl-CpG-Binding protein 2-null embryonic stem cells: a system for studying Rett syndrome. Brain Res 2010 in press.","DOI":"10.1016\/j.brainres.2010.08.090"},{"key":"10.1016\/j.braindev.2010.12.007_b0270","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410003360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410003360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:22:13Z","timestamp":1559938933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760410003360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0387760410003360"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2010.12.007","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}